- Corporate Officers - M
- Merrifield C Ann
Insider Trading History of Merrifield C Ann
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Merrifield C Ann since 2007.
This trader's CIK number is 1247224.
At the time of last reporting, Merrifield C Ann was the Director of Lyra Therapeutics, Inc.. (stock ticker symbol LYRA).
Also see all insider trading activities at Lyra Therapeutics, Inc..
Note that in the past
MERRIFIELD C ANN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Playtex Products Inc (PYX) by Merrifield C Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | PYX | 0 | $0 | 0 | $0 | 9,000 | $87,750 |
Yearly summary of insider trading at Lyra Therapeutics, Inc. (LYRA) by Merrifield C Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | LYRA | 7,828 | $38,685 | 0 | $0 | 0 | $0 |
| 2021 | LYRA | 3,500 | $31,395 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Invivo Therapeutics Holdings Corp. (NVIV) by Merrifield C Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | NVIV | 3,636 | $0 | 0 | $0 | 0 | $0 |
| 2015 | NVIV | 2,000 | $24,718 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Flexion Therapeutics Inc (FLXN) by Merrifield C Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | FLXN | 8,000 | $101,120 | 0 | $0 | 0 | $0 |
| 2016 | FLXN | 1,000 | $13,387 | 0 | $0 | 0 | $0 |
| 2015 | FLXN | 1,000 | $23,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Juniper Pharmaceuticals Inc (JNP) by Merrifield C Ann
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | JNP | 2,000 | $11,260 | 0 | $0 | 0 | $0 |
| 2015 | JNP | 4,600 | $49,120 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Merrifield C Ann:
1. Playtex Products Inc (PYX)
2. Lyra Therapeutics, Inc. (LYRA)
3. Invivo Therapeutics Holdings Corp. (NVIV)
4. Flexion Therapeutics Inc (FLXN)
5. Juniper Pharmaceuticals Inc (JNP)
Table 1. Insider trading of Playtex Products Inc (PYX) by Merrifield C Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-05-22 | PYX | Option Ex | 9,000 | 9.75 | 87,750 |
Table 2. Insider trading of Lyra Therapeutics, Inc. (LYRA) by Merrifield C Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-10 | LYRA | Buy | 4,000 | 5.05 | 20,200 |
| 2022-05-13 | LYRA | Buy | 3,500 | 4.81 | 16,845 |
| 2022-05-16 | LYRA | Buy | 328 | 5.00 | 1,640 |
| 2021-06-17 | LYRA | Buy | 3,500 | 8.97 | 31,395 |
Table 3. Insider trading of Invivo Therapeutics Holdings Corp. (NVIV) by Merrifield C Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-10 | NVIV | Buy | 3,636 | .00 | 0 |
| 2015-08-12 | NVIV | Buy | 2,000 | 12.36 | 24,718 |
Table 4. Insider trading of Flexion Therapeutics Inc (FLXN) by Merrifield C Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-05-23 | FLXN | Buy | 8,000 | 12.64 | 101,120 |
| 2016-06-14 | FLXN | Buy | 1,000 | 13.39 | 13,387 |
| 2015-09-11 | FLXN | Buy | 1,000 | 23.00 | 23,000 |
Table 5. Insider trading of Juniper Pharmaceuticals Inc (JNP) by Merrifield C Ann
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-08-26 | JNP | Buy | 2,000 | 5.63 | 11,260 |
| 2015-12-04 | JNP | Buy | 1,600 | 12.14 | 19,420 |
| 2015-08-13 | JNP | Buy | 1,000 | 9.96 | 9,960 |
| 2015-08-14 | JNP | Buy | 2,000 | 9.87 | 19,740 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Merrifield C Ann
(Director of Lyra Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.